Join a Study

CHIPTS-affiliated Studies


The UCLA CARE Center is currently enrolling participants for a 2 year study looking at the safety and acceptability of an injectable drug that may be used to prevent HIV

• HIV negative?
• Between 18 and 65?
• At low risk for HIV?

For more Information, about this study, visit

Call 310-557-9062 or email to schedule a screening visit


To download flyer, click  here (224)


This study is still open to HIV+ women (treatment naïve). Please pass to colleagues/friends/professionals who may benefit.

Enrollment of men has greatly exceeded enrollment of women across the globe. It is important that participation of women adequately represent the HIV+ population to be able to determine safety/effectiveness across genders.

Childcare reimbursement, transportation assistance, and flexible hours are available. Compensation is also provided for time/travel.

If you are, or know any HIV+ women ready to start treatment for the first time, please have them contact me at:

Office: 310-550-2271

Cell: 209-628-0589

Please note enrollment has closed to males. Women participating in the study will need to continue care with their primary provider to receive medical care and medications not associated with the study.

To view flyer click here.